Abstract. Allicin is an oxygenated carotenoid derivative that exhibits strong antioxidant activity, which effectively removes reactive oxygen species from the body and has important roles in disease prevention and treatment. Therefore, the present study aimed to investigate whether allicin attenuates lipopolysaccharide (LPS)-induced acute lung injury (ALI) in neonatal rats and the potential underlying mechanisms. An LPS-induced ALI neonatal rat model was utilized to assess the therapeutic value and mechanisms of allicin. Following allicin treatment, increases in lung wet/dry ratio and the lung protein concentration were significantly suppressed in LPS-induced ALI neonatal rats. Furthermore, ELISA results demonstrated that allicin significantly reduced the levels of malondialdehyde, tumor necrosis factor-α and interleukin-6, and increased superoxide dismutase activity, in the bronchoalveolar lavage fluid of LPS-treated rats. Additionally, allicin administration increased the protein expression of Bcl-2 and reduced the activity of caspase-3/-9, as determined by western blotting or ELISA, respectively, and increased phosphatidylinositol 3-kinase (PI3K) and phosphorylated-Akt protein levels, in LPS-treated ALI neonatal rats. The results of the present study indicate that allicin attenuate LPS-induced ALI in neonatal rats by ameliorating oxidative stress, inflammation and apoptosis via the PI3K/Akt pathway. Allicin may be used for development of a novel drug for treatment of ALI.
Introduction
Comprehensive studies on acute respiratory distress syndrome (ARDS) have revealed that ARDS is the most severe stage of the continuous pathological process of acute lung injury (ALI); ALI is observed in all cases of ARDS, however ALI does necessarily develop into ARDS. It is also established that ALI is implicated in system inflammatory response syndrome (SIRS) (1, 2) . The lung is vulnerable to damage and a role in SIRS (3) . ALI commonly leads to severe hypoxemia, thereby leading to the dysfunction of other organs and potentially multiple organ failure (4) . Therefore, ALI is the initial stage in the whole pathological process of SIRS, which results in organ dysfunction and subsequent multiple organ failure.
Newborns, particularly premature children, are prone to ALI, which may develop into ARDS. In severe cases, bronchopulmonary dysplasia impairs lung development, which is closely associated with the development of lung maturity (5) . ALI may initially develop in utero and continue following birth. Pulmonary inflammation can cause lung damage and lead to ALI (5) . The lung of a newborn is in cyst and alveolar period, which is immature (6) . Pulmonary surfactant is observed after 28 weeks gestation, meaning that premature children are vulnerable to ALI and the further development and maturation are affected. A lower gestational age is associated with an increased risk of lung damage (7, 8) .
Allicin is a type of volatile, oily matter that is extracted from spherical garlic bulbs and is the major component of garlic biological activity. Allicin is reported to exhibit various biological functions and physiological effects, including anti-inf lammation, anti-cancer, cholesterol-lowering, anti-platelet aggregation and liver-protection effects, and also functions in preventing heart and vascular diseases and lowering blood pressure (9) (10) (11) (12) (13) (14) . The aim of the current study was to investigate whether allicin attenuates lipopolysaccharide (LPS)-induced ALI in neonatal rats and whether these beneficial actions may be mediated by ameliorating oxidative stress, inflammation and apoptosis. 100, where total number refers to the number of rats in each group at the start of the experiment (n=20). The chemical structure of allicin is presented in Fig. 1 .
Materials and methods

Animals
Lung wet/dry (W/D) ratio of LPS-treated rats and the lung concentration of proteins.
The rats were euthanized using intravenous injection of 35 mg/kg pentobarbital and sacrificed using decollation. The thorax was opened and the whole lungs were immediately removed. The superior lobe of the right lung was harvested, weighed and dried at 80˚C for 48 h, and subsequently reweighed to calculate the W/D weight ratio of the lung tissue. Bronchoalveolar lavage fluid (BALF) was collected to determine the lung concentration of proteins via the BCA method (Wuhan Boster Biological Technology, Co., Ltd., Wuhan, China.)
Histological examination. Histological examination was used to determine whether the induction of the model was successful. The rats were euthanized using intravenous injection of 35 mg/kg pentobarbital and decapitation. Right lung tissue was immersed in 10% neutral phosphate-buffered formaldehyde fixative for 24 h at room temperature and embedded in paraffin. Tissue was cut into 4 µm sections and stained with hematoxylin and eosin (HE) for 15 min at room temperature. Tissue sections were subsequently observed using a Nikon SMZ 1500 light microscope (magnification, x40; Nikon Corporation, Tokyo, Japan).
Oxidative stress and inflammation. The left lung of each rat was harvested and washed with ice-cold PBS. The volume of BALF was similar in each group and centrifuged at 1,200 x g for 10 min at 4˚C. The supernatant was collected to determine the levels of interferon (IFN)-γ, caspase-3 activity, caspase-9 activity, glutathione (GSH), glutathione peroxidase (GSH-PX), malondialdehyde (MDA), tumor necrosis factor (TNF)-α and interleukin (IL)-6, -1β and -10 levels, and superoxide dismutase (SOD) activity, using rat IFN-γ (cat. no. H025), caspase-3 activity (cat. no. G015), caspase-9 activity (cat. no. G018), GSH (cat. no. A006-2), GSH-PX (cat. no. A005), MDA (cat. no. A003-1), TNF-α (cat. no. H052), IL-1β (cat. no. H002), IL-10 (cat. no. H009), IL-6 (cat. no. H007) and SOD (cat. no. A001-1-1) ELISA kits (Wuhan Boster Biological Technology, Co., Ltd.). The concentration of proteins was measured using the BCA method.
Western blotting. BALF was collected following centrifugation at 10,000 x g for 10 min at 4˚C to determine the concentration of proteins via the BCA method. An equal amount of protein (50 µg) was separated by 10-12% SDS-PAGE, and transferred to and immobilized on a nitrocellulose membrane (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The nitrocellulose membrane was blocked by incubation with PBS containing 5% non-fat dried milk for 2 h at room temperature and subsequently incubated with primary antibodies against COX-2 (cat. no. 12282; 1:2,000; Cell Signaling Technology, Inc), NF-κB (cat. no. 8242; 1:2,000; Cell Signaling Technology, Inc), PI3K (cat. no. 4249; 1:2,000; Cell Signaling Technology, Inc), Akt (cat. no. 4691; 1:2,000; Cell Signaling Technology, Inc), p-Akt (cat. no. 4060; 1:2,000; Cell Signaling Technology, Inc), GAPDH (cat. no. D110016; 1:5,000; Sangon Biotech Co., Ltd., Shanghai, China) overnight at 4˚C. The nitrocellulose membrane was washed three times with TBS containing 0.1% Tween-20 and incubated with horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibody (cat. nos. sc-2004 and sc-2005 respectively, both 1:5,000; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) for 2 h at room temperature. Subsequently, the membrane was incubated with chemiluminescence reagent (ECL Plus Western Blotting Detection System; GE Healthcare, Chicago, IL, USA). Proteins were quantitatively analyzed using Image-Pro Plus 6.0 software (Media Cybernetics, Inc., Rockville, MD, USA).
Statistical analysis. Data are presented as the mean ± standard deviation and were analyzed using SPSS 19 (IBM Corp., Armonk, NY, USA). All data were analyzed by one-way analysis of variance followed by Dunnett's post hoc test. P<0.05 was considered to indicate a statistically significant difference.
Results
Effect of allicin on the mortality rate of LPS-treated neonatal rats. The survival of rats in the ALI model group began to decrease at 24 h after treatment with allicin, compared with the sham group (Fig. 2) . Allicin inhibited the mortality rate of LPS-treated rats at various time-points, compared with the ALI model group (Fig. 2) .
Effect of allicin on histological examination of LPS-treated neonatal rats.
As demonstrated in Fig. 3 , alveolar edema, hemorrhage, wall thickening and hyperinflation, and inflammatory cell infiltration into the alveolar and interstitial spaces, of the model group were higher compared with the sham group. However, treatment with allicin reduced the LPS-induced alveolar edema, hemorrhage, wall thickening and hyperinflation, and inflammatory cell infiltration into the alveolar and interstitial spaces, in ALI rats (Fig. 3) . Fig. 4 , the lung W/D ratio and lung protein concentration in the ALI model group were higher compared with the sham group (Fig. 4) . However, allicin administration significantly decreased the elevations in lung W/D ratio and lung protein concentration, compared with the ALI model group (Fig. 4) .
Effect of allicin on lung W/D ratio and protein concentration in LPS-induced ALI neonatal rats. As demonstrated in
Effect of allicin on the levels of MDA, and activity of SOD, glutathione (GSH) and GSH peroxidase (GSH-PX), in the BALF of LPS-treated neonatal rats.
Compared with the sham group, the levels of MDA were significantly increased, and SOD, GSH and GSH-PX activity was significantly inhibited, in the ALI model group (Fig. 5) . However, allicin treatment significantly reversed the effects of LPS on MDA levels, and SOD, GSH and GSH-PX activity, compared with the ALI model group (Fig. 5) . Fig. 6A -C, the levels of TNF-α, IL-1β and IL-6 in the BALF of ALI model rats were significantly increased, compared with the sham group. However, TNF-α, IL-1β and IL-6 levels were significantly suppressed by treatment with allicin, compared with the ALI model group (Fig. 6A-C) . In addition, the levels of IL-10 in the BALF of ALI model rats were lower compared with the sham group (Fig. 6D) . Treatment with allicin significantly increased IL-10 levels in ALI rats, compared with the ALI model group (Fig. 6D) .
Effect of allicin on inflammation in the BALF of LPS-treated neonatal rats. As demonstrated in
Effect of allicin on inflammatory pathways. The levels of interferon (IFN)-γ, and the protein expression of cyclooxygenase (COX)-2 and nuclear factor-κB (NF-κB), in the BALF were significantly promoted in ALI model rats, compared with the sham group (Fig. 7) . However, allicin treatment significantly reduced IFN-γ levels, and COX-2 and NF-κB protein expression, in ALI rats, compared with the ALI model group (Fig. 7) .
Effect of allicin on anti-apoptotic protein of Bcl-2 and caspase-3/-9 pathway.
The results of ELISA and western blotting also demonstrated that upregulation of caspase-3/-9 activity and the inhibition of Bcl-2 protein expression, respectively, in the ALI model group compared with the sham group (Fig. 8) . However, upregulation of caspase-3/-9 activity and the inhibition of Bcl-2 protein expression were induced by allicin administration, compared with the ALI model group (Fig. 8) .
Effect of allicin on the phosphatidylinositol 3-kinase (PI3K) and phosphorylated (p)-Akt pathway.
The protein expression of PI3K and p-Akt was significantly reduced in the ALI model group, compared with the sham group (Fig. 9) . However, PI3K and p-Akt protein expression levels were significantly increased by treatment with allicin, compared with the ALI model group (Fig. 9) . 
Discussion
Oxidative stress is an important mechanism in the pathogenesis of ALI (16) . A large number of oxygen free radicals (OFR) are produced during the ALI process by various cell types within the vessel wall, including endothelial cells, vascular smooth muscle cells and cells of the outer membrane (17) . The present study demonstrated that allicin reduced increases in the lung W/D ratio that were observed in the ALI model group, and identified that it may have potential as a drug for the treatment of ALI.
Oxidative stress leads to increases in cell permeability, cell edema and potentially lytic necrosis (18) . The targets of OFR include nucleic acids, proteins and membrane lipids, and lipid peroxidation is one of the primary mechanisms of free radical damage (19) . MDA is employed as a marker for lipid peroxidation to reflect the degree of oxidative stress injury following ALI. To combat oxidative stress injury, various endogenous cytoprotective substances are generated in the lung tissue, such as SOD, which may be used as an indicator of antioxidative activity (20) . A dynamic equilibrium exists between oxidation and antioxidant systems in vivo; when these systems become imbalanced, tissue damage results and the lung is one of the most vulnerable target organs (21) . A previous study demonstrated that MDA content was increased significantly in ALI rat lung homogenates, while SOD level was decreased significantly, which indicates that an imbalance between the oxidation and antioxidant system may be involved in the pathogenesis of ALI (22) . Furthermore, the results of the current study demonstrated that allicin treatment significantly reversed the effects of ALI model induction on MDA, SOD, GSH and GSH-PX levels in ALI neonatal rats.
The development of ALI may be initiated by alveolar inflammation under the perinatal asphyxia or infection, as well as additional internal and external factors (23) . The number and activation of neutrophils is increased, which increases the release of various inflammatory mediators, and epithelial and endothelial cells functions are subsequently damaged, which is a major mechanism in the pathogenesis of ALI (23) . It is reported that IL-6 combines with heparin sulfate glycoprotein on the vascular endothelial cell surface, which has a potent chemotactic effect and causes endothelial cells to adhere to and activate neutrophils (24) . Therefore, the release of IL-6 is considered to be an important factor in the pathogenesis of ALI (25) . In addition, TNF-α also has an important role in the inflammatory lesion of tissue and promotes the release of other inflammatory mediators (26) . The results of the present study demonstrated that allicin significantly suppressed TNF-α, IL-1β, IL-6 and IFN-γ levels, and COX-2 and NF-κB protein expression, and increased IL-10 levels, in ALI neonatal rats.
Apoptosis is a type of programmed cell death that is important in the development and injury of multicellular organisms in various tissues and organs (27) . Caspases and the Bcl-2 protein family are closely associated with apoptosis (28) . Apoptosis-associated genes are divided into apoptosis-promoting genes and apoptosis-inhibiting genes (29) . Caspase-3 activation leads to the induction of cell apoptosis, and has an important role in the initiation and implementation of early apoptosis. Caspase-3 activation is a biochemical indicator of early apoptosis. Bcl-xl is an anti-apoptotic gene that exerts anti-apoptosis effects by inhibiting the activation of caspase proteases (30) . Proapoptotic genes are dominant during early apoptosis, during which Bcl-xl expression is decreased, and as apoptosis develops, the internal anti-apoptotic mechanism is activated (31) . The present study demonstrated that allicin significantly increased the expression of the Bcl-2 anti-apoptotic protein and inhibited caspase-3/-9 activity in ALI model neonatal rats, which may occur via the PI3K/Akt pathway. Ding et al reported that allicin inhibited oxidative stress-induced mitochondrial dysfunction and apoptosis of osteoblast cells through PI3K/Akt signaling (32) . The present study only analyzed the effects of allicin on PI3K/Akt signaling in ALI, which is a limitation of the study as allicin may also regulate additional signaling pathways to exert effects on inflammation, oxidative stress and apoptosis, which should be investigated in future studies.
In conclusion, the present study demonstrated that allicin treatment suppressed lung W/D ratio and the lung concentration of proteins in ALI neonatal rats. These beneficial effects may be due to its ability to inhibit oxidative stress and inflammation, and to inhibit apoptosis, including Bcl-2 expression, caspase-3/-9 activityin ALI neonatal rats, which may occur via the PI3K/Akt pathway. Therefore, allicin may have potential as a novel drug for the treatment of neonatal ALI.
